More reasons than ever why general practice needs support

1 March 2018

Practices have compelling reasons to work together. They need the collective strength to gain an equal voice in CCGs, STPs and other organisations responsible for local integrated care systems. They have strong business reasons to seek efficiencies and new sources of income. They have a pressing need to develop workforce capacity and skills. Practices can also expect increasing external pressure for change, as NHS England’s latest planning guidance has made it clear that all practices are expected to work in groupings covering populations of at least 30,000-50,000. PCC now offers a comprehensive range of support to enable practices to start to work together effectively, or where federations and other grouping are already up and running, help them to take their next steps with confidence. Our support includes personal and team training, events, local workshops and business planning. To find out more, email enquiries@pcc-cic.org.uk.   

 

Support updates Our news

Latest News

New toolkit to help keep information safe

18 May 2018

NHS Digital has launched the new Data Security and Protection toolkit, replacing the previous Information Governance toolkit, to help keep patient information safe.

The Data Security and Protection toolkit is an online self-assessment tool that enables health and social care organisations to measure and publish their performance against the National Data Guardian’s ten data security standards.

All organisations that have access to NHS patient data and systems – including NHS Trusts, primary care and social care providers and commercial third parties – must complete the Toolkit to provide assurance that they are practising good data security and that personal information is handled correctly.

Read More

NICE approves multiple sclerosis drugs after prices are reduced

18 May 2018

Reductions to the price of three multiple sclerosis (MS) drugs mean NICE is now able to recommend them for routine NHS funding.

NICE has published draft guidance recommending interferon beta-1b (Extavia, Novartis), glatiramer acetate (Copaxone, Teva UK Ltd), and interferon beta-1a (Avonex, Biogen Idec Ltd, and Rebif, Merck Serono Ltd) – as treatment options for people with a type of MS called relapsing-remitting MS.

Read More

Personal health budgets and integrated personal budgets: extending legal rights

18 May 2018

This consultation seeks views on giving more people the right to have personal health budgets and integrated personal budgets.

The consultation closes on 8 June.

Read More

After a diagnosis of dementia: what to expect from health and care services

18 May 2018

A guide to the support people should get from local services in England if they or someone they know have been diagnosed with dementia.

Read More

Supporting and applying research in the NHS

18 May 2018

At the NHS England public board meeting on 30 November 2017, NHS England and the National Institute for Health Research (NIHR) published a joint statement that committed to 12 actions to support and apply research in the NHS. Between November 2017 and February 2018, NHS England, working with the Department of Health and Social Care, the Health Research Authority and the NIHR launched a public consultation on proposals to better manage excess treatment costs and eliminate delays and further improve commercial clinical research set-up and reporting. The response document summarises the feedback received and outlines our next steps for implementation.

Read More